Results 11 to 20 of about 5,007,317 (352)
Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer. [PDF]
PLoS ONE, 2018 Although human papillomavirus (HPV) positive oral and oropharyngeal cancers have distinct epidemiologic and molecular characteristics compared to HPV-negative cancers, all patients with oral and oropharyngeal cancers received same standard regimen ...
Yi Rang Kim +4 more
doaj +1 more source
Frontiers in Oncology, 2023 BackgroundIt was reported that educational attainment and household income are associated with oropharyngeal cancer. However, whether such an association is causal is still unknown.MethodsThe Mendelian randomization (MR) design was performed to ...
Li Qi +5 more
doaj +1 more source
Oral Complications from Oropharyngeal Cancer Therapy
Cancers, 2023 Simple Summary Although oropharyngeal cancers are increasing in incidence, more patients are surviving their cancer therapy. Once a patient has completed their oropharyngeal cancer treatment, they need to contend with the multiple side effects related to
V. Sankar, Yuanming Xu
semanticscholar +1 more source
Cancer, 2022 New ultrasensitive methods for detecting residual disease after surgery are needed in human papillomavirus–associated oropharyngeal squamous cell carcinoma (HPV+OPSCC).
Connor J O'Boyle +23 more
semanticscholar +1 more source
Viruses, 2022 Recent trends have shown a dramatic rise in the incidence of oropharyngeal squamous cell carcinoma strongly associated with high-risk human papillomavirus (HPV) of type 16.
Christine Kottaridi +10 more
doaj +1 more source
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer
Cancer, 2021 Case‐control studies from the early 2000s demonstrated that human papillomavirus–related oropharyngeal cancer (HPV‐OPC) is a distinct entity associated with number of oral sex partners.
Virginia E. Drake +18 more
semanticscholar +1 more source
Cancer Stem Cells in Oropharyngeal Cancer [PDF]
Cancers, 2021 Oropharyngeal cancer (OPC), which is a common type of head and neck squamous cell carcinoma (HNSCC), is associated with tobacco and alcohol use, and human papillomavirus (HPV) infection. Underlying mechanisms and as a result prognosis of the HPV-positive and HPV-negative OPC patients are different.
Mehmet Gunduz +4 more
openaire +2 more sources
BMC Public Health, 2020 Background Human papillomavirus (HPV) is associated with a significant public health burden, yet few studies have been conducted in Asia, especially on noncervical cancers.
Inseon Choi +3 more
doaj +1 more source
Cancer Control, 2021 Objectives Human papillomavirus (HPV)-associated cancers account for about 9% of the cancer mortality burden in the United States; however, survival differs among sociodemographic factors.
Nosayaba Osazuwa-Peters PhD, BDS, MPH, CHES +5 more
doaj +1 more source
Historical Perspective: How the Discovery of HPV Virus Led to the Utilization of a Robot
Frontiers in Oral Health, 2022 The treatment of oropharyngeal cancer has undergone many paradigms shifts in recent decades. First considered a surgical disease, improvements in radiotherapy led to its popularization in the 1990s. Subsequently, the discovery of the human papillomavirus
Grégoire B. Morand +4 more
doaj +1 more source